Resultado de búsqueda
Bristol Myers Squibb is a global biopharmaceutical company committed to discovering, developing and delivering innovative medicines to patients with serious diseases.
- Patients & Caregivers
At Bristol Myers Squibb, we are committed to helping you get...
- Healthcare Providers
Bristol Myers Squibb provides information and resources to...
- Researchers
Bristol Myers Squibb wishes to advance science through...
- Investors
Forward-looking statements contained on this website should...
- Business Development
Bristol Myers Squibb emphasizes business development through...
- News
Visit the Bristol Myers Squibb newsroom & stay up to date...
- About Us
At Bristol Myers Squibb, we work every day to transform...
- Careers
At Bristol Myers Squibb, your work helps people prevail over...
- Patients & Caregivers
Conozca más sobre Bristol Myers Squibb y sobre nuestra misión para descubrir, desarrollar y proporcionar medicinas innovadoras a pacientes con enfermedades graves.
BMS es una compañía que ofrece medicamentos innovadores para enfermedades graves como el cáncer, la esclerosis múltiple y la psoriasis. Conoce sus historias, campañas, ensayos clínicos y premios en su web corporativa española.
Bristol-Myers Squibb es una compañía farmacéutica estadounidense que se formó en 1989 por la fusión de Bristol-Myers y Squibb. Fabrica productos para tratar enfermedades como cáncer, VIH/SIDA, diabetes y hepatitis, y ha sido reconocida por su investigación innovadora y su sostenibilidad.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Get the latest stock price, news, quote and history of Bristol-Myers Squibb, a biopharmaceutical company that offers products for various diseases. See its performance, earnings, dividends, and key events.
26 de sept. de 2024 · Bristol Myers Squibb to Present Data at ESMO Demonstrating Ongoing Leadership in Immuno-Oncology and Progression of Assets from Its Differentiated Research Platforms